End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 25 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Apr. 25 | Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million | MT |
Financials (USD)
Sales 2024 * | 4.66B | Sales 2025 * | 4.86B | Capitalization | 4.43B |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | 101M | EV / Sales 2024 * | 1.63 x |
Net Debt 2024 * | 3.18B | Net Debt 2025 * | 3.01B | EV / Sales 2025 * | 1.53 x |
P/E ratio 2024 * |
-87.5
x | P/E ratio 2025 * |
58.3
x | Employees | - |
Yield 2024 * |
3.37% | Yield 2025 * |
3.58% | Free-Float | 99.69% |
Latest transcript on Perrigo Company PLC
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 23-06-29 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 22-05-15 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 20-12-14 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 17-02-05 |
Bradley Alford
BRD | Director/Board Member | 67 | 17-02-05 |
1st Jan change | Capi. | |
---|---|---|
+34.00% | 704B | |
+25.05% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+14.85% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |